The Art and Science of Using Diuretics in the Treatment of Heart Failure in Diverse Clinical Settings

Abstract

It is important to understand the rationale for appropriate use of different diuretics, alone or in combination, in different heart failure patients, under diverse clinical settings. Clinicians and nurses engaged in heart failure care, must be familiar with different diuretics, their appropriate doses, methods of administration, monitoring of the responses, and the side-effects. Inappropriate use of diuretics, both under-treatment and overtreatment, and poor follow-up can lead to failures, and adverse outcomes. Adequate treatment of congestion, with rather aggressive use of diuretics, is necessary, even if that may worsen renal function temporarily in some patients. Diuretic treatment should later be titrated down, by early recognition of the euvolemic sate, which can be assessed by clinical examination, measurement of the natriuretic peptides, and when possible, echocardiographic estimation of the left ventricular filling pressure. You need to treat patients, who are truly resistant to the loop diuretics, by administering the diuretics as intravenous bolus injection followed by continuous infusion, and/or by sequential nephron blockade by adding the thiazide diuretics. You need to use the diuretics based on a sound understanding of the pathophysiology of the disease process, the pharmacokinetics and pharmacodynamics of the diuretics, even when strong evidences for your choices might be lacking. Some patients may benefit from injection of loop diuretics together with hypertonic saline, and others from injection of loop diuretics with albumin. Patient education, and regular follow up of the treatment of heart failure patients, in out-patient settings are important for reducing the rates of complications, and for reducing the needs for urgent hospitalizations.

Albumin infusion in hospitalized patients with acute heart failure: a retrospective cohort study

“…Intravenous albumin can be applied to avert or manage hypotension or to assist with fluid drainage. However, this is a contentious technique [ 19 , 20 ]. Although intravenous albumin is widely thought to be safe, it is also quite costly.…”

Progress in the treatment of diabetic cardiomyopathy, a systematic review

“…127 However, the overuse of diuretics can cause reduced tissue perfusion, renal impairment, water-electrolyte disturbances, and occasionally gastrointestinal symptoms. 127,128 F I G U R E 4 The current advantages and disadvantages of DCM treatments.…”

Which is the best strategy for using diuretics in decompensated chronic heart failure?

“…Absorption of bumetanide and torsemide is quite complete. These two drugs have a longer duration effect but are more expensive and not available in many countries [16]. The plasma halflives of LD range from 1 hour (bumetanide) to 3-4 hours (torsemide), with an intermediate half-life for furosemide (Table 1).…”